KESTRA MEDICAL TECHNOLOGIES, LTD. — Form 4
Filed September 10, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 46/100
What the filing says
Director Hanley Conor (KMTS) sold 6K shares (~$144K) on the open market (30% of holdings). Large sale — ~30% of holdings.
Why this rating
Large sale — ~30% of holdings.
See more from September 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.